10 Short Squeeze Candidates: Unicycle Therapeutics, Compass Pathways, Virgin Orbit Among Those To Watch

Potential short squeeze plays gained steam in 2021 and continued through 2022 with new traders looking for the next huge move.

High short interest and a high cost to borrow are among the common traits that could lead to a short squeeze.

Here’s a look at the top five short squeeze candidates this week based on the Fintel short squeeze leaderboard.

Related Link: What Is A Short Squeeze?

Unicycle Therapeutics Inc (NASDAQ: UNCY): Biotechnology company Unicycle moves up 37 positions on the leaderboard to rank first for the week. Data shows 39.6% of the float short and a cost to borrow of 241.1%. The stock got several analyst updates and price target increases in recent weeks on the heels of a funding round to help with the commercialization of lead drug Renazorb.

Kala Pharmaceuticals Inc (NASDAQ: KALA): Kala returns to the top five positions on the leaderboard with an 11-position jump for the week to rank second. Data shows 12.6% of the float short and a cost to borrow of 644.2%. Last week, the stock was 14.2% of …

Full story available on Benzinga.com

Read More

Tags

Share this post:

JOIN THE HYVE

Gain insights, receive dynamic opportunities directly to your inbox. Sign up now…